Related references
Note: Only part of the references are listed.Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses
Baris Ata et al.
HUMAN REPRODUCTION UPDATE (2021)
Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis
Adrija Kumar Datta et al.
HUMAN REPRODUCTION UPDATE (2021)
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?
Antonio La Marca et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2019)
Cumulative live birth rates in low-prognosis women
Jori A. Leijdekkers et al.
HUMAN REPRODUCTION (2019)
Progestin-primed ovarian stimulation improves the outcomes of IVF/ICSI cycles in infertile women with diminished ovarian reserve
Chun-Mei Yu et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study
Qian Peng et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2019)
Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome
Bei Xu et al.
FERTILITY AND STERILITY (2018)
Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline
Alan Penzias et al.
FERTILITY AND STERILITY (2018)
Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve
Rong Yu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders
Chen-Yu Huang et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)
Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women
Nikolaos P. Polyzos et al.
FERTILITY AND STERILITY (2018)
Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women ≥ 38 years old
Marta Devesa et al.
HUMAN REPRODUCTION (2018)
Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
Yun Wang et al.
TRIALS (2018)
Mild stimulation for in vitro fertilization
Geeta Nargund et al.
FERTILITY AND STERILITY (2017)
New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF
Nathalie Massin
HUMAN REPRODUCTION UPDATE (2017)
Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles
V. S. Vanni et al.
PLOS ONE (2017)
Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study
Ningling Wang et al.
CLINICAL ENDOCRINOLOGY (2016)
Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Panagiotis Drakopoulos et al.
HUMAN REPRODUCTION (2016)
Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study
Maria Giulia Minasi et al.
HUMAN REPRODUCTION (2016)
Ovarian ageing: the role of mitochondria in oocytes and follicles
Pascale May-Panloup et al.
HUMAN REPRODUCTION UPDATE (2016)
Younger poor ovarian response women achieved better pregnancy results in the first three IVF cycles
Yajuan Yang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2016)
Elevated Progesterone Levels on the Day of Oocyte Maturation May Affect Top Quality Embryo IVF Cycles
Bo Huang et al.
PLOS ONE (2016)
Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization
Yanping Kuang et al.
FERTILITY AND STERILITY (2015)
Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders
Trifon G. Lainas et al.
HUMAN REPRODUCTION (2015)
Shifting Paradigms in Diminished Ovarian Reserve and Advanced Reproductive Age in Assisted Reproduction: Customization Instead of Conformity
Beverly G. Reed et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2015)
Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles
David E. Reichman et al.
FERTILITY AND STERILITY (2014)
Mild vs. long protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial
Alberto Revelli et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2014)
Oral Progestin Priming Increases Ovarian Sensitivity to Gonadotropin Stimulation and Improves Luteal Function in the Cat
Rosemary A. Stewart et al.
BIOLOGY OF REPRODUCTION (2012)
The role of gonadotropins in the follicular phase
Ioannis E. Messinis et al.
WOMEN'S HEALTH AND DISEASE (2010)
Human Ovarian Reserve from Conception to the Menopause
W. Hamish B. Wallace et al.
PLOS ONE (2010)
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis
Dimitra Kyrou et al.
FERTILITY AND STERILITY (2009)
Reproductive outcome in patients with diminished ovarian reserve
AJ Levi et al.
FERTILITY AND STERILITY (2001)
Share Paper
